Search results for: 'AMI Infrastructure Developments across Asia'

The Asia-Pacific medical imaging and informatics market revenue is forecast to increase by 11.4% in 2023, mainly driven by the high procurement of medical imaging equipment and radiology IT solutions in the informatics sector. Large hospitals widely adopt digital radiography and ultrasound systems as the devices are operator-dependent and need a sk...

13 Sep 2021  |  North America  |  Market Research

Global Small Molecule Contract Development and Manufacturing Organization (CDMO) Growth Opportunities

Emerging Pharmaceuticals and Highly Potent Complex Molecules Creating Future Growth Potential

Infographics

×

This study presents Frost & Sullivan’s overall market and segment-wise revenue forecasts of the global small molecule contract development and manufacturing organization (CDMO) industry. It highlights key growth opportunities for small molecule CDMOs based on the main evolution in their business models and strategic approaches as well as those of p...

Full product development IVD CMO comprises companies that partner with OEMs and support them in the development of IVD devices, ranging from concept to commercialization. IVD companies are continuously looking at new ways to optimize resources due to rising cost pressures and regulatory complexities, prompting industry participants to adopt innovat...

More than 6,000 molecules are currently in clinical development across the pharmaceutical research and development (R&D) landscape, with more than 11,000 in the preclinical phase. The industry is witnessing the growth of small- to mid-segment pharma/biotech players making significant contributions to drug discovery and development pipelines. Across...

The study analyses the Kenyan and Rwandan health care landscape, market outlook, and investment and growth opportunities. It also discusses the drivers and restraints and the dynamics of the hospital construction market and concludes by providing a list of upcoming projects and strategic recommendations for the markets in Kenya and Rwanda. The res...

The Asia-Pacific next-generation diagnostics market's revenue is projected to decline by 5.0% in 2023, attributed to the reduced demand for COVID-19-related testing. Rapid expansion in non-COVID molecular diagnostics and point-of-care testing (POCT) will not be sufficient to drive the overall recovery of the region. As companies continue to focus o...

03 Jul 2015  |  Asia Pacific  |  Market Research

Analysis of The Telemedicine Market in Asia-Pacific

Affordable Telemedicine Services Are Enabling Business Model Evolution

Infographics

×

Telemedicine is not a new concept in healthcare; it has been practiced in the form of pilots and charitable projects for over a decade across Asia-Pacific countries. However, recent advancements in information and communication technologies have led to a significant decrease in the costs associated with telemedicine, spurring a sudden market boom. ...

The global smart hospital market is entering a pivotal growth phase, moving beyond pilot deployments into enterprise-wide transformation. Smart hospitals represent a digitally enabled model of care delivery, built on the integration of IoT, interoperability, AI, digital twins, and extended care models such as hospital-at-home and virtual care. In t...

The main objective of this research is to estimate test volumes and unit prices for a wide variety of LDTs (genetic) and a few high volume FDA tests for selective therapeutic areas. The tests are categorized by their intended uses across the diagnostic spectrum (risk assessment, screening, diagnosis, staging and prognosis, therapy selection, therap...